Back to Agenda
International Coalition of Medicines Regulatory Authorities (ICMRA): Harnessing Achievements During COVID-19 for the Future
Session Chair(s)
Agnès Saint-Raymond, DrMed
Head of Division International Affairs
European Medicines Agency, Netherlands
There is an on-going need for coordination, ownership, and oversight of the various changes, improvements, and flexibilities that have emerged through the pandemic. While this is a multipronged problem, the regulatory coordination, flexibility and speed are paramount. ICMRA and their achievements that were the most visible during COVID-19 will be discussed including global regulatory collaboration and its impact during the pandemic. Additionally, a panel discussion on the role of ICMRA for the future of convergence, and the impact of achievements during COVID-19 on its strategic initiatives and technical workstreams will be included.
Learning Objective : Identify the role and activities of ICMRA; Discuss the collaboration within ICMRA during COVID-19; Describe ICMRA achievements beyond COVID-19.
Speaker(s)
How Regulatory Cooperation and Convergence has Helped COVID Vaccines Gain Authorization Globally
Charbel Haber, PhD, MBA, MPH
Moderna, United States
Senior Vice President, Head of Regulatory Affairs
COVID-19 Experience and How ICMRA’s Efforts Supported Development of Vaccines and Therapeutics
Sean Curtis, MD, MPH
MSD, United States
Senior Vice President, Global Regulatory Affairs and Clinical Safety
ICMRA’s Achievements from the Perspective of NiFDS
Kyung Won Seo
Ministiry of Food and Drug Safety, Korea, Republic of
Director General, National Institute of Food and Drug Safety Evaluation
ICMRA Vaccine Pharmacovigilance
John Skerritt, PhD
Australia
Retired, Australian Department of Health
ICMRA's Achievements From ANVISA's Perspective
Antonio Barra Torres, MD
ANVISA, Brazil
President Director
ICMRA's Achievements From EMA's Perspective
Emer Cooke, MBA, MSc
The European Medicines Agency, Netherlands
Executive Director, Chair, ICMRA
ICMRA's Achievements From Health Canada's Perspective
Pierre Sabourin, MBA
Health Canada, Canada
Assistant Deputy Minister, Health Products and Food Branch
Have an account?